Clinical trial
Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and…
NCT00127959 · International Antiviral Therapy Evaluation Center, Other · Completed
Key facts
| NCT number | NCT00127959 |
|---|---|
| Title | Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection |
| Official title | Virological and Clinical Anti-HBV Efficacy of Tenofovir and Emtricitabine in Antiretroviral Naïve Patients With HIV/HBV co-Infection |
| Lead sponsor | International Antiviral Therapy Evaluation Center, Other |
| Collaborators | Gilead Sciences Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Hepatitis B |
| Intervention type | Drug |
| Interventions | tenofovir, emtricitabine, zidovudine, efavirenz |
| Enrollment | 24 |
| Start date | Mar 1, 2004 |
| Completion | Aug 1, 2006 |
| First posted | Aug 9, 2005 |
| Last update posted | Apr 24, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: